Pharmacokinetics of homoharringtonine in dogs
Authors:
- 1 April 1988
- journal article
- conference paper
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 21 (2) , 139-142
Abstract
We studied the pharmacokinetics and distribution of homoharringtonine (HHT), an antitumor alkaloid, in anesthetized dogs using chromatographic and radiochemical techniques. Uniformly tritiated HHT was administered i.v. to five dogs at doses of 0.05 to 0.34 mg/kg, 200 μCi per animal. Unchanged HHT disappeared in a triphasic manner from the plasma with an initial plasma t1/2 of 9.4±4.2 min, an intermediary t1/2 of 1.4±0.5 h, and a terminal t1/2 of 40.6±4.6 h. The plasma clearance was 114.0±20.1 ml/kg-1 h-1 and the steady-state volume of distribution was 6.2±0.71/kg. In 72 h, 40.1%±4.0% of the administered radioactivity was excreted in the urine, 17.8%±2.7% of which was unchanged HHT. HHT was metabolized extensively to one major and two minor metabolites. Biliary excretion of total radioactivity was 14.4% in 5 h, 2% of which was HHT. HHT concentration in the CSF was highest 4 h after drug administration, about 40% of the concentration in the concurrent plasma. At autopsy 5 h after dosing, the highest percentage of HHT was in the liver (7.4%), follwed by the small intestine (2.5%), stomach (1.0%), pancreas (0.8%), kidneys (0.8%), and lungs (0.7%). The heart, spleen, large intestine, and brain each retained less than 0.5%. However, 24 h after dosing, 4% of the HHT still remained in the liver, 1% in the small intestine, and less than 1% in the other organs. HHT seems to be extensively metabolized in dogs and partially retained in the body.Keywords
This publication has 7 references indexed in Scilit:
- CLINICAL-PHARMACOLOGY OF HOMOHARRINGTONINE1986
- Homoharringtonine: an effective new drug for remission induction in refractory nonlymphoblastic leukemia.Journal of Clinical Oncology, 1985
- PHASE-I CLINICAL INVESTIGATION OF HOMOHARRINGTONINE1984
- Cephalotaxine esters in the treatment of acute leukemia. A preliminary clinical assessment.1976
- Inhibition of Protein Synthesis in Intact HeLa CellsAntimicrobial Agents and Chemotherapy, 1975
- Harringtonine, an Inhibitor of Initiation of Protein BiosynthesisMolecular Pharmacology, 1975
- Antitumor Alkaloids from Cephalotaxus harringtonia: Structure and ActivityJournal of Pharmaceutical Sciences, 1972